Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Review1
- Historical Article1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Radiology1
Search Results
Sort by
- Book[edited by] G. Michael Felker, Douglas L. Mann.Contents:
Molecular basis of heart failure
Cellular basis for heart failure
Cellular basis for myocardial regeneration and repair
Myocardial basis for heart failure : role of cardiac interstitium
Molecular signaling mechanisms of the renin-angiotensin system in heart failure
Adrenergic receptor signaling in heart failure
Role of innate immunity in heart failure
Oxidative stress in heart failure
Natriuretic peptides in heart failure: pathophysiologic and therapeutic implications
Systolic dysfunction in heart failure
Alterations in ventricular function : diastolic heart failure
Alterations in ventricular structure : role of left ventricular remodeling and reverse remodeling in heart failure
Alterations in the sympathetic and parasympathetic nervous systems in heart failure
Alterations in the peripheral circulation in heart failure
Alterations in kidney function associated with heart failure
Alterations in skeletal muscle in heart failure
Alterations in cardiac metabolism in heart failure
Epidemiology of heart failure
Heart failure as a consequence of ischemic heart disease
Heart failure as a consequence of dilated cardiomyopathy
Restrictive and infiltrative cardiomyopathies and arrhythmogenic right ventricular dysplasia/cardiomyopathy
Cardiac amyloidosis
Heart failure as a consequence of hypertrophic cardiomyopathy
Heart failure as a consequence of genetic cardiomyopathy
Heart failure as a consequence of hypertension
Heart failure as a consequence of valvular heart disease
Heart failure as a consequence of congenital heart disease
Heart failure as a consequence of viral and nonviral myocarditis
Heart failure in the developing world
Heart failure and human immunodeficiency virus
Clinical evaluation of heart failure
Cardiac imaging in heart failure
Biomarkers and precision medicine in heart failure
Hemodynamics in heart failure
Disease prevention in heart failure
Acute heart failure
Contemporary medical therapy for heart failure patients with reduced ejection fraction
Management of arrhythmias and device therapy in heart failure
Treatment of heart failure with preserved ejection fraction
Management of heart failure in special populations : older patients, women, and racial/ethnic minority groups
Stem cell-based and gene therapies in heart failure
Neuromodulation in heart failure
Pulmonary hypertension
Heart transplantation
Circulatory assist devices in heart failure
Cardio-oncology and heart failure
Disease management and telemedicine in heart failure
Management of comorbidities in heart failure
Quality and outcomes in heart failure
Decision making and palliative care in advanced heart failureDigital Access ClinicalKey 2020 - ArticleFletcher GH.Radiology. 1978 Apr;127(1):3-19.In his overview of the history and theoretical developments of radiotherapy, the author stresses the following concepts: (a) sensitivity is not linked to histology but to the volume of cancer; (b) the dose must not necessarily be homogeneous in the target volume but related to varying volumes of cancer; (c) the fact that irradiation may not be the sole treatment in some tumors does not mean that it does not have a place in their management; (d) as a general rule, large tumors should not be treated with irradiation only, if gross cancer can be resected simply; (e) since there is a dose-response curve for control rates and for complications, an optimum dose level must be maintained; and (f) the patient's quality of life is a major concern.